Drugs / trimethoprim/sulfamethoxazole
re-read 3 minutes ago

trimethoprim/sulfamethoxazole

Developed for
urinary tract infection
Investigated by
Baylor College of Medicine

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00789464 — urinary tract infection Baylor College of Medicine Withdrawn No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as trimethoprim/sulfamethoxazole ClinicalTrials.gov intervention name — accepted as the source's own label NCT00789464 ↗
Route Oral “standardized oral antibiotic prophylaxis” NCT00789464 ↗